跳至主要内容
临床试验/CTRI/2021/10/037630
CTRI/2021/10/037630尚未招募2 期

Clinical Trial to Evaluate the Safety and Efficacy of Siddha Medicine Nandhi Mezhugu in Stage 1 and 2 Breast Cancer Patients

Central Council for Research in Siddha Arumbakkam Chennai0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Female patients in the age group of 18- 60 years
  • 2.Patients with histologically/cytologically confirmed carcinoma of the breast of stages I & II.
  • 3.Patient willing to take siddha medicine
  • 4.Patients ready to consent and to abide to trial related procedures

排除标准

  • 1.Patient willing to take chemotherapy/radiotherapy/ undergo surgery/ any other alternative medicines
  • 2.Patients who have received prior chemotherapy/ hormonal therapy/ investigational drugs/ alternative therapies for the treatment of breast cancer within last 1 month
  • 3.Patients who have under gone surgery for stage I & II breast cancer
  • 4.Patients with stage III and IV (who are with distant metastasis at diagnosis)
  • 5.Patients with severe illness
  • 6.Patients with significant existing breast trauma
  • 7.Patients with abnormal renal & liver functions
  • 8.Confirmed diagnosis of HIV or Hepatitis B/C
  • 9.Inability to comply with the study protocol
  • 10.Pre-menopausal female patients who are pregnant, lactating or of reproductive potential and not employing effective birth control measures

研究者

发起方
Central Council for Research in Siddha Arumbakkam Chennai

相似试验

Clinical Trial of Siddha Medicine Nandhi Mezhugu in... | 临床试验